Search Results 311-320 of 13185 for pharmacogenetics

  1. Biliary Regenerative Medicine: Robert C. Huebert - Mayo Clinic Research

    Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...

  2. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  3. Overview - Genetics Epigenetics and Metabolomics Core - Mayo Clinic Research

    The Genetics, Epigenetics and Metabolomics Core of the Mayo Clinic Pirnie Translational PKD Center provides services for polycystic kidney disease (PKD) and ...

  4. Genetics, Epigenetics and Metabolomics Core (Mayo Clinic Pirnie Translational Polycystic Kidney Disease Center)

    The Genetics, Epigenetics and Metabolomics Core of the Mayo Clinic Pirnie Translational PKD Center provides services for polycystic kidney disease (PKD) and ...

  5. Human and Integrative Physiology and Clinical Pharmacology Laboratory - Overview

    The Human and Integrative Physiology and Clinical Pharmacology Lab of Michael J. Joyner, M.D., at Mayo Clinic studies response to physical and mental stress ...

  6. Afamelanotide (subcutaneous route) - Side effects & uses - Mayo Clinic

    Afamelanotide implant is used to increase pain free light exposure in patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP).

  7. A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER).

  8. Marie C. Hogan, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic nephrologist Marie C. Hogan, M.D., Ph.D., researches causes and treatments for polycystic kidney disease (PKD), autosomal dominant PKD and liver ...

  9. Pharmacogenomics and Post-Operative Nausea and Vomiting - Mayo Clinic

    The hypothesis is that using genotypic variation in CYP2D6 to select the appropriate 5HT3 serotonin receptor antagonist to treat PONV will decrease rates of ...

  10. Publications - Rachel A. Batdorf, M.D. - Mayo Clinic

    Sadarangani SP, Batdorf R, Buchhalter LC, Mrelashvili A, Banerjee R, Henry NK, Huskins WC, Boyce TG. Clostridium septicum brain abscesses in a premature ...